Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) EBITDA: 2014-2025

Historic EBITDA for Ocugen (OCGN) over the last 11 years, with Sep 2025 value amounting to -$20.0 million.

  • Ocugen's EBITDA fell 54.18% to -$20.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.0 million, marking a year-over-year decrease of 25.10%. This contributed to the annual value of -$54.0 million for FY2024, which is 14.36% up from last year.
  • Per Ocugen's latest filing, its EBITDA stood at -$20.0 million for Q3 2025, which was down 35.47% from -$14.8 million recorded in Q2 2025.
  • In the past 5 years, Ocugen's EBITDA registered a high of -$7.1 million during Q1 2021, and its lowest value of -$26.0 million during Q2 2021.
  • In the last 3 years, Ocugen's EBITDA had a median value of -$14.8 million in 2025 and averaged -$15.2 million.
  • Per our database at Business Quant, Ocugen's EBITDA slumped by 618.10% in 2021 and then skyrocketed by 50.99% in 2023.
  • Quarterly analysis of 5 years shows Ocugen's EBITDA stood at -$14.6 million in 2021, then plummeted by 53.61% to -$22.4 million in 2022, then soared by 50.99% to -$11.0 million in 2023, then fell by 26.22% to -$13.9 million in 2024, then crashed by 54.18% to -$20.0 million in 2025.
  • Its EBITDA stands at -$20.0 million for Q3 2025, versus -$14.8 million for Q2 2025 and -$15.4 million for Q1 2025.